Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile

Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile

The objective of the study is to evaluate the efficacy of monitoring after discharge of patients with high-risk acute coronary syndrome.

The objective of the study is to evaluate the efficacy of monitoring after discharge of patients with high-risk acute coronary syndrome.

Inclusion Criteria:

• Patient is able to understand the nature of study and has provided written informed consent.
• Patient with Acute Coronary Syndrome, with or without elevation of the ST segment at the EKG (the last with elevation of troponins).
• Patient with coronariography at the episode of ACS showing severe lesions treated with stent.
• Patient with risk index for 6-month mortality (GRACE score) of more than 118.
• Patient with risk index for stroke (CHA2DS2-VACS score) of more than 2.

Exclusion Criteria:

• Patient with history of AF.
• Patient with episodes of AF during admission at the current episode.
• Patient with pacemaker or ICD (implantable cardioverter-defibrillator) previously.
• Patient with indication of pacemaker or ICD in current or short-term phase.
• Patient is participating in another interventional clinical investigation.
• Patient is pregnant or breast feeding.
• Patient´s life-expectancy is less than 24 months.